BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 25644512)

  • 1. Metformin use and lung cancer risk in patients with diabetes.
    Sakoda LC; Ferrara A; Achacoso NS; Peng T; Ehrlich SF; Quesenberry CP; Habel LA
    Cancer Prev Res (Phila); 2015 Feb; 8(2):174-9. PubMed ID: 25644512
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Cohort Study of Metformin and Colorectal Cancer Risk among Patients with Diabetes Mellitus.
    Bradley MC; Ferrara A; Achacoso N; Ehrlich SF; Quesenberry CP; Habel LA
    Cancer Epidemiol Biomarkers Prev; 2018 May; 27(5):525-530. PubMed ID: 29716927
    [No Abstract]   [Full Text] [Related]  

  • 3. Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus.
    Tseng CH
    Diabetes Metab Res Rev; 2015 Sep; 31(6):619-26. PubMed ID: 25820555
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin significantly reduces incident prostate cancer risk in Taiwanese men with type 2 diabetes mellitus.
    Tseng CH
    Eur J Cancer; 2014 Nov; 50(16):2831-7. PubMed ID: 25201464
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin decreases lung cancer risk in diabetic patients in a dose-dependent manner.
    Tsai MJ; Yang CJ; Kung YT; Sheu CC; Shen YT; Chang PY; Huang MS; Chiu HC
    Lung Cancer; 2014 Nov; 86(2):137-43. PubMed ID: 25267165
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative safety of diabetes medications and risk of incident invasive breast cancer: a population-based cohort study.
    Calip GS; Yu O; Elmore JG; Boudreau DM
    Cancer Causes Control; 2016 May; 27(5):709-20. PubMed ID: 27053250
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin and lung cancer risk in patients with type 2 diabetes mellitus.
    Tseng CH
    Oncotarget; 2017 Jun; 8(25):41132-41142. PubMed ID: 28456789
    [TBL] [Abstract][Full Text] [Related]  

  • 8. No reduced risk of overall, colorectal, lung, breast, and prostate cancer with metformin therapy in diabetic patients: database analyses from Germany and the UK.
    Kowall B; Stang A; Rathmann W; Kostev K
    Pharmacoepidemiol Drug Saf; 2015 Aug; 24(8):865-74. PubMed ID: 26132313
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The use of metformin and the incidence of lung cancer in patients with type 2 diabetes.
    Smiechowski BB; Azoulay L; Yin H; Pollak MN; Suissa S
    Diabetes Care; 2013 Jan; 36(1):124-9. PubMed ID: 22923670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reduced risk of lung cancer with metformin therapy in diabetic patients: a systematic review and meta-analysis.
    Zhang ZJ; Bi Y; Li S; Zhang Q; Zhao G; Guo Y; Song Q
    Am J Epidemiol; 2014 Jul; 180(1):11-4. PubMed ID: 24920786
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antidiabetic medication, statins and the risk of endometrioid endometrial cancer in patients with type 2 diabetes.
    Arima R; Marttila M; Hautakoski A; Arffman M; Sund R; Ilanne-Parikka P; Kangaskokko J; Läärä E; Puistola U; Hinkula M
    Gynecol Oncol; 2017 Sep; 146(3):636-641. PubMed ID: 28645427
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metformin is associated with a lower risk of colorectal cancer in Taiwanese patients with type 2 diabetes: A retrospective cohort analysis.
    Tseng CH
    Diabetes Metab; 2017 Oct; 43(5):438-445. PubMed ID: 28438547
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin use and survival after colorectal cancer: A population-based cohort study.
    Mc Menamin ÚC; Murray LJ; Hughes CM; Cardwell CR
    Int J Cancer; 2016 Jan; 138(2):369-79. PubMed ID: 26331456
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin and the incidence of viral associated cancers in patients with type 2 diabetes.
    Hicks BM; Yin H; Sinyavskaya L; Suissa S; Azoulay L; Brassard P
    Int J Cancer; 2017 Jul; 141(1):121-128. PubMed ID: 28393359
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin may reduce bladder cancer risk in Taiwanese patients with type 2 diabetes.
    Tseng CH
    Acta Diabetol; 2014 Apr; 51(2):295-303. PubMed ID: 24509842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Use of metformin and risk of kidney cancer in patients with type 2 diabetes.
    Tseng CH
    Eur J Cancer; 2016 Jan; 52():19-25. PubMed ID: 26630530
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin Treatment and Cancer Risk: Cox Regression Analysis, With Time-Dependent Covariates, of 320,000 Persons With Incident Diabetes Mellitus.
    Dankner R; Agay N; Olmer L; Murad H; Keinan Boker L; Balicer RD; Freedman LS
    Am J Epidemiol; 2019 Oct; 188(10):1794-1800. PubMed ID: 31269196
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between Metformin Use and Mortality after Cervical Cancer in Older Women with Diabetes.
    Han K; Pintilie M; Lipscombe LL; Lega IC; Milosevic MF; Fyles AW
    Cancer Epidemiol Biomarkers Prev; 2016 Mar; 25(3):507-12. PubMed ID: 26721670
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of smoking and concomitant metformin use with cardiovascular events and mortality in people newly diagnosed with type 2 diabetes.
    Paul SK; Klein K; Majeed A; Khunti K
    J Diabetes; 2016 May; 8(3):354-62. PubMed ID: 25929583
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin is associated with decreased skin cancer risk in Taiwanese patients with type 2 diabetes.
    Tseng CH
    J Am Acad Dermatol; 2018 Apr; 78(4):694-700. PubMed ID: 29246826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.